GRCE · Grace Therapeutics, Inc.

$2.08 -0.02 (-0.95%)

Market Cap

$44.18M

21.04M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Prashant Kohli	Chief Executive Officer	$579,000	—	—	$391,820	$289,500	$10,500	$1,270,820
Amresh Kumar	Vice President, Program Management	$310,000	—	—	$52,150	$93,000	$10,500	$465,650
Carrie D’Andrea	Former Vice President, Clinical Operations	$310,000	—	—	$52,150	$93,000	$10,500	$465,650

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Prashant Kohli	Chief Executive Officer	$500,000	—	—	$324,621	$250,000	—	$1,074,621
Carrie D’Andrea	Vice President, Clinical Operations	$286,000	—	—	$49,763	$85,800	—	$421,563
Amresh Kumar	Vice President, Program Management	$286,000	—	—	$49,763	$85,800	—	$421,563

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Prashant Kohli	Chief Executive Officer	$399,970	—	—	$387,660	$200,000	—	$987,630
Carrie D’Andrea	Vice President, Clinical Operations	$248,250	—	—	$52,250	$82,500	—	$383,000
Amresh Kumar	Vice President, Program Management	$243,269	—	—	$52,250	$82,500	—	$378,019

Executive changes

Person	Role	Change	Effective	Filed
Carrie D’Andrea	Vice President of Clinical Operations	Terminated	2026-06-05	2026-06-05

Key facts CIK 1444192 CUSIP 00439U104 13F (30d) 27 filings 27 filers Visit website Investor relations